Rivaroxaban Impurity 84 | CAS 3481-09-2 - Request Quote
Rivaroxaban Impurity 84
| SZ CAT No: | SZ-R017137 |
| CAS No | 3481-09-2 |
| Mol.F. | C8H4ClNO2 |
| Mol.Wt. | 181.6 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rivaroxaban Impurity 84 is chemically 2-Chloroisoindoline-1,3-dione. Rivaroxaban Impurity 84 is supplied with detailed characterization data compliant with regulatory guideline. Rivaroxaban Impurity 84 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rivaroxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 3481-09-2
Purchase 3481-09-2
Order 3481-09-2
Enquire 3481-09-2
price of 3481-09-2
3481-09-2 Supplier
3481-09-2 Manufacturer
3481-09-2 Exporter
buy high quality Rivaroxaban Impurity 84
Purchase Rivaroxaban Impurity 84
Rivaroxaban Impurity 84 suppliers
Rivaroxaban Impurity 84 manufacturers
Rivaroxaban Impurity 84 price
Order Rivaroxaban Impurity 84
Enquire Rivaroxaban Impurity 84
Rivaroxaban Impurity 84 cost
Rivaroxaban Impurity 84 Supplier
Rivaroxaban Impurity 84 Distributor
Rivaroxaban Impurity 84 for Method Validation
Rivaroxaban Reference Standard
Rivaroxaban Impurity 84 for ANDA Filing
Rivaroxaban Impurity 84 for Forced Degradation Studies
Rivaroxaban Impurity 84 Identification Standards
Rivaroxaban Impurity 84 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


